14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $23.53 $28.69 Friday, 3rd May 2024 INSM stock ended at $25.55. This is 0.429% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.06% from a day low at $25.40 to a day high of $26.43.
90 days $23.53 $29.91
52 weeks $18.09 $32.00

Historical Insmed prices

Date Open High Low Close Volume
Jul 19, 2023 $21.11 $21.22 $20.81 $21.11 607 552
Jul 18, 2023 $20.73 $21.19 $20.68 $20.92 699 533
Jul 17, 2023 $20.70 $21.19 $20.58 $20.70 624 481
Jul 14, 2023 $21.06 $21.10 $20.50 $20.60 826 263
Jul 13, 2023 $20.59 $21.08 $20.29 $20.97 1 369 664
Jul 12, 2023 $20.30 $20.58 $20.01 $20.31 1 018 626
Jul 11, 2023 $20.29 $20.32 $19.97 $20.02 719 820
Jul 10, 2023 $19.80 $20.52 $19.74 $20.40 743 461
Jul 07, 2023 $20.24 $20.38 $19.84 $19.86 623 558
Jul 06, 2023 $20.41 $20.44 $19.96 $20.23 802 262
Jul 05, 2023 $20.89 $21.28 $20.53 $20.65 1 173 484
Jul 03, 2023 $20.97 $21.06 $20.61 $20.75 501 840
Jun 30, 2023 $20.51 $21.21 $20.35 $21.10 829 388
Jun 29, 2023 $20.15 $20.45 $19.92 $20.32 876 807
Jun 28, 2023 $19.99 $20.18 $19.77 $20.15 646 123
Jun 27, 2023 $19.99 $20.20 $19.68 $19.97 601 064
Jun 26, 2023 $19.85 $20.08 $19.68 $19.91 786 799
Jun 23, 2023 $20.19 $20.25 $19.79 $19.96 1 060 444
Jun 22, 2023 $20.71 $20.82 $20.25 $20.34 770 816
Jun 21, 2023 $20.18 $20.71 $19.76 $20.69 1 131 864
Jun 20, 2023 $19.91 $20.40 $19.71 $20.21 1 030 678
Jun 16, 2023 $20.51 $20.51 $19.64 $20.00 1 467 636
Jun 15, 2023 $19.28 $20.02 $19.01 $20.01 820 006
Jun 14, 2023 $19.43 $19.56 $18.78 $19.29 1 127 503
Jun 13, 2023 $19.46 $19.68 $19.22 $19.42 750 267
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT